Literature DB >> 1082388

Enhanced uptake by guinea-pig macrophages of radio-iodinated human aggregated immunoglobulin G in the presence of sera from rheumatoid patients with cutaneous vasculitis.

I I Onyewotu, P M Johnson, G D Johnson, E J Holborow.   

Abstract

A competitive radiobioassay method for soluble immune complexes in sera has been used to study sera from patients with rheumatoid arthritis. Twenty-eight out of sixty-two sera from selected seropositive rheumatoid patients were found to produce enhanced uptake of radio-iodinated human aggregated IgG by guinea-pig macrophages in contrast with the inhibition of uptake seen with SLE sera. Twenty-two out of the twenty-eight enhancing sera belonged to patients with cutaneous vasculitis. None of the twenty-two sera from seronegative rheumatoid patients possessed enhancing properties and none of these patients had clinical evidence of vasculitis. Three patients with seropositive SLE had sera with enhancing properties and had cutaneous vasculitis. We have shown that the enhancement is probably due to the presence in sera of immune complexes or altered IgG bound to rheumatoid factor. The possible mechanism has been investigated and it appears that there is increased binding of radio-iodinated aggregated IgG to free valencies on rheumatoid factor already bound to immune complexes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1082388      PMCID: PMC1538093     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  ANTINUCLEAR FACTOR IN RHEUMATOID ARTHRITIS, ITS INCIDENCE AND CLINICAL SIGNIFICANCE.

Authors:  D J WARD; G D JOHNSON; E J HOLBOROW
Journal:  Ann Rheum Dis       Date:  1964-07       Impact factor: 19.103

2.  THE ASSOCIATION OF RHEUMATOID FACTOR WITHANTINUCLEAR FACTOR ACTIVITY.

Authors:  J N MCCORMICK; J DAY
Journal:  Lancet       Date:  1963-09-14       Impact factor: 79.321

3.  1958 REVISION of diagnostic criteria for rheumatoid arthritis.

Authors: 
Journal:  Arthritis Rheum       Date:  1959-02

4.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

5.  Biologic activity of soluble antigen-antibody complexes. V. Change of optical rotation by the formation of skin reactive complexes.

Authors:  K ISHIZAKA; D H CAMPBELL
Journal:  J Immunol       Date:  1959-09       Impact factor: 5.422

6.  Phagocytosis of particulate complexes of gamma-globulin and rheumatoid factor.

Authors:  R L PARKER; F R SCHMID
Journal:  J Immunol       Date:  1962-04       Impact factor: 5.422

7.  Detection and radioassay of soluble circulating immune complexes using guinea pig peritoneal exudate cells.

Authors:  I I Onyewotu; E J Holborow; G D Johnson
Journal:  Nature       Date:  1974-03-08       Impact factor: 49.962

8.  Properties of macrophage receptors for cytophilic antibodies.

Authors:  J G Howard; B Benacerraf
Journal:  Br J Exp Pathol       Date:  1966-04

9.  BRIEF NOTES ON THE NATURAL HISTORY OF RHEUMATOID ARTHRITIS.

Authors:  E G BYWATERS
Journal:  Can Med Assoc J       Date:  1964-09-12       Impact factor: 8.262

10.  Characterization of the reactant (gamma globulin factor) in the F II precipitin reaction and the F II tanned sheep cell agglutination test.

Authors:  C L CHRISTIAN
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307

View more
  12 in total

1.  Reticuloendothelial phagocytosis in patients with nephritis.

Authors:  I I Onyewotu
Journal:  Br Med J       Date:  1976-03-13

2.  The effect of sera from patients with connective tissue diseases on red cell binding and phagocytosis by monocytes.

Authors:  A Temple; G Loewi
Journal:  Immunology       Date:  1977-07       Impact factor: 7.397

3.  Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

Authors:  R H Zubler; U Nydegger; L H Perrin; K Fehr; J McCormick; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

4.  Circulating immune complexes in patients with cryptogenic fibrosing alveolitis.

Authors:  P L Haslam; B Thompson; I Mohammed; P J Townsend; M E Hodson; E J Holborow; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

Review 5.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

6.  The biological properties of immunoglobulin G and its split products [F(ab')2 and Fab].

Authors:  H H Sedlacek; P Gronski; T Hofstaetter; E J Kanzy; H U Schorlemmer; F R Seiler
Journal:  Klin Wochenschr       Date:  1983-08-01

7.  Effect of penicillamine therapy on circulating immune complexes in rheumatoid arthritis.

Authors:  I Mohammed; D Barraclough; E J Holborow; B M Ansell
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

8.  Effect of penicillamine treatment on immune complexes in two cases of seropositive juvenile rheumatoid arthritis.

Authors:  F P Bresnihan; B M Ansell
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

9.  Digital vasculitis after splenectomy in a patient with Felty's syndrome.

Authors:  M Comer; R C Bucknall
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

10.  Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositions.

Authors:  H H Sedlacek
Journal:  Klin Wochenschr       Date:  1980-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.